Developer docs
API playgroundTry for free, no card

Search company profiles

ProCure Treatment Centers

Full company profile

uuid0009dpc

Namestring
ProCure Treatment Centers
Legal namestring
ProCure Proton Therapy Center
Websiteurl
procure.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

ProCure Treatment Centers develops and operates a network of proton therapy centers in the United States. Founded in 2005 and headquartered in New York, the company operates its flagship facility in Somerset, New Jersey, which opened in March 2012 as the first proton therapy center in the tri-state area (New Jersey, New York, Connecticut). The Somerset facility has treated more than 8,000 patients since inception, including over 750 pediatric cases, and runs a care team of 251–500 employees across physicians, oncology nurses, support staff, and administrative personnel.

ProCure's core offering is proton therapy, an advanced form of radiation treatment that uses positively charged protons generated by a cyclotron instead of photons, allowing radiation to be deposited directly into the tumor and stop, thereby reducing exposure to surrounding healthy tissue. The Somerset facility is equipped with four specialized treatment rooms (two inclined-beam, one fixed-beam, and one 360-degree gantry), Pencil Beam Scanning (PBS), robotic patient positioning, real-time imaging, and the SpaceOAR Hydrogel spacer for prostate treatment. The center treats prostate, breast, brain, head and neck, lung, gastrointestinal, and pediatric cancers, with five-year cancer-free rates of 99% for early/intermediate prostate cancer and 76% for advanced prostate cancer, and up to 60% less radiation to the rectum, bladder, and bowel versus X-ray-based treatments.

ProCure generates revenue through professional services billed to Medicare, private insurers, and patients directly; treatment is covered by Medicare and many private insurance providers, with dedicated financial counselors supporting insurance navigation. The go-to-market combines physician referrals and clinical affiliations with major hospital systems (Hackensack Meridian Health, NYU Langone Health, Northwell Health, The Cancer Center at CentraState), a referral relationship with Memorial Sloan Kettering, and physician practice integration with Princeton Radiation Oncology. Demand generation is layered with event-driven patient education (Welcome Wednesdays/Tuesdays information sessions, specialty cancer awareness campaigns) and a content-marketing program of patient testimonials.

Short descriptiontext

ProCure Treatment Centers develops and operates proton therapy centers in the United States, operating its flagship Somerset, New Jersey facility delivering Pencil Beam Scanning treatment for prostate, breast, brain, pediatric, and other cancers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
proton therapy services, radiation oncology, particle beam therapy, pencil beam scanning, cancer treatment centers
Industry3 codes
1Radiation Oncology
CodeHLAKAFACPrimaryYes
2Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryNo
3Medical Oncology
CodeHLAKAFABPrimaryNo
NAICS code2 codes
  • Offices of Physicians62111
  • Diagnostic Imaging Centers621512
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Health Services8000
Product category
Radiation Oncology
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Proton Therapy Treatment Services
TypeProfessional Services
Description

ProCure generates revenue by providing proton therapy cancer treatment services to patients. Treatments are billed to insurance providers, Medicare, and patients directly. The center offers treatment for multiple cancer types including prostate, breast, brain, head and neck, lung, gastrointestinal, and pediatric cancers.

procure.com
2Consultation and Information Services
TypeProfessional Services
Description

Free information sessions are provided to educate potential patients about proton therapy. Paid consultations are scheduled for patients interested in pursuing treatment.

procure.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Insurance-covered treatment
ModelOtherBilling cadenceMulti-year contract
Notes

Proton therapy is covered by Medicare and many private insurance providers. Patients should contact their insurance provider to confirm coverage. Financial counselors are available to assist with insurance verification and navigation.

procure.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

ProCure Treatment Centers operates the ProCure Proton Therapy Center in Somerset, New Jersey, delivering proton radiation therapy to cancer patients as a direct medical service. The center offers Pencil Beam Scanning treatment across multiple cancer types, supported by a cyclotron, robotic patient positioning, real-time imaging, and SpaceOAR Hydrogel for rectal protection, and accepts patients through physician referrals, hospital partnerships, and direct inquiries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 99% cancer-free rate for early and intermediate prostate cancer at five years post-treatment
+5 more records
Product overview1 text field

ProCure Proton Therapy Center offers a unified suite of cancer treatment services centered on proton therapy as its core offering. The center provides Pencil Beam Scanning proton therapy as its most advanced treatment option, complemented by SpaceOAR Hydrogel for rectal protection during prostate treatments. Patient-facing services include free Information Sessions, a Patient Portal for health information access, Online Bill Pay, and an Ambassador Program for peer support. The facility also offers facility tours and connects patients to clinical trials. Treatment is available for multiple cancer types including prostate, breast, brain, head and neck, lung, gastrointestinal, and pediatric cancers.

Product and service6 records
1Proton Therapy
Categorycore treatment
Description

Advanced form of radiation treatment that destroys cancer cells by delivering radiation directly into the tumor and stopping, reducing exposure to surrounding healthy tissue. It is FDA-approved and used to treat prostate, breast, brain, head and neck, lung, gastrointestinal, and pediatric cancers.

2Free Information Sessions
Categorypatient education service
Description

Free educational sessions at the ProCure Somerset facility where prospective patients can learn about proton therapy, meet the care team, and tour the facility.

3Patient Portal
Categorypatient service
Description

Online portal through ProCure's clinical partner Optimal Care for patients to access their health information and manage their care.

4Online Bill Pay
Categorypatient service
Description

Online payment service for patients to pay their proton therapy treatment bills through the ProCure website.

5Ambassador Program
Categorypatient support service
Description

Peer support program where former ProCure patients share their experiences with new patients facing similar cancer journeys.

6Cyclotron Tour
Categorypatient education service
Description

Guided tour of ProCure's cyclotron equipment used to generate proton beams for treatment, offered to patients and visitors.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical affiliation partnership where Hackensack Meridian Health refers patients to ProCure for proton therapy treatment. The partnership enables continued advancement of research and technology for proton therapy. Hackensack Meridian Health is one of the leading hospital systems in New Jersey with top cancer programs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical affiliation with NYU for proton therapy treatment referrals. NYU is a renowned academic medical center with leading cancer programs that collaborates with ProCure to bring proton therapy to patients.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical affiliation with Northwell Health for proton therapy referrals. Northwell Health is one of the largest health systems in New York providing comprehensive cancer care and partners with ProCure to expand access to proton therapy.

4The Cancer Center at CentraState
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Hospital partnership providing comprehensive cancer care beyond proton therapy. The Cancer Center at CentraState offers surgery, chemotherapy, hormone therapy, and immunity therapy, along with palliative care, survivorship programs, and post-treatment wellness resources. The partnership ensures patients receive comprehensive care before, during, and after proton therapy treatment.

procure.com
Strategic tierCoreTypeTechnology or Integration
Description

Physician practice partnership where radiation oncologists from Princeton Radiation Oncology treat patients at ProCure. Multiple physicians including Dr. Brian Chon, Dr. Henry Tsai, and Dr. Andrew Greenberg work with both ProCure and Princeton Radiation Oncology, enabling seamless patient care and treatment coordination.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Referral relationship where Memorial Sloan Kettering refers patients to ProCure for proton therapy when appropriate. Dr. Yu Yao, a radiation oncologist at Memorial Sloan Kettering, referred a nasopharyngeal cancer patient to ProCure for proton therapy treatment.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major radiation therapy equipment manufacturer and solutions provider, including linear accelerators and stereotactic systems. Competes with proton therapy on the cost/benefit axis for conventional radiation oncology.

TypeBroad incumbent
Description

Dominant radiation oncology equipment vendor (proton, photon, IMRT, CyberKnife) and increasingly an integrated cancer care operator. Not a direct clinical peer, but shapes the technology and competitive landscape ProCure operates within.

TypeDirect peer
Description

Academic-affiliated proton therapy program treating comparable indications with Pencil Beam Scanning. Overlaps with ProCure in clinical capability and target patient population.

TypeDirect peer
Description

Regional proton therapy center serving the Midwest with cancer indications and technology comparable to ProCure. Geographic non-overlap but same patient mix and referral dynamics.

TypeDirect peer
Description

Independently operated proton therapy center in the Dallas-Fort Worth area, treating prostate, breast, lung, and pediatric cancers. Comparable standalone model and competitive positioning within a regional market.

TypeDirect peer
Description

Independent, privately-financed proton therapy operator with multiple treatment rooms and a similar outpatient, multi-cancer treatment model. Directly comparable as a non-academic, single-market proton center.

TypeDirect peer
Description

High-volume academic proton therapy program treating a similar multi-cancer population (prostate, breast, head/neck, lung, pediatric). Comparable technology stack and physician depth, though embedded in a larger hospital system.

TypeDirect peer
Description

One of the original U.S. proton therapy centers, operating at Massachusetts General Hospital with similar Pencil Beam Scanning capability and a tertiary, multi-indication patient mix. Directly comparable clinical model and physician training pathway.

9Memorial Sloan Kettering Cancer Center Proton Therapy
TypeDirect peer
Description

Operates a multi-room proton facility in the NY metro area, directly competing with ProCure for tri-state patients and referral relationships. Already a referral source for ProCure for select cases.

TypeDirect peer
Description

One of the largest standalone proton therapy centers in the U.S., treating a high volume of prostate, breast, lung, head/neck, and pediatric cancers. Closest analog to a multi-state proton therapy network operator.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ProCure Treatment Centers

Radiation Oncologyprocure.com

ProCure Treatment Centers develops and operates proton therapy centers in the United States, operating its flagship Somerset, New Jersey facility delivering Pencil Beam Scanning treatment for prostate, breast, brain, pediatric, and other cancers.

What ProCure Treatment Centers does

ProCure Treatment Centers develops and operates a network of proton therapy centers in the United States. Founded in 2005 and headquartered in New York, the company operates its flagship facility in Somerset, New Jersey, which opened in March 2012 as the first proton therapy center in the tri-state area (New Jersey, New York, Connecticut). The Somerset facility has treated more than 8,000 patients since inception, including over 750 pediatric cases, and runs a care team of 251–500 employees across physicians, oncology nurses, support staff, and administrative personnel.

ProCure's core offering is proton therapy, an advanced form of radiation treatment that uses positively charged protons generated by a cyclotron instead of photons, allowing radiation to be deposited directly into the tumor and stop, thereby reducing exposure to surrounding healthy tissue. The Somerset facility is equipped with four specialized treatment rooms (two inclined-beam, one fixed-beam, and one 360-degree gantry), Pencil Beam Scanning (PBS), robotic patient positioning, real-time imaging, and the SpaceOAR Hydrogel spacer for prostate treatment. The center treats prostate, breast, brain, head and neck, lung, gastrointestinal, and pediatric cancers, with five-year cancer-free rates of 99% for early/intermediate prostate cancer and 76% for advanced prostate cancer, and up to 60% less radiation to the rectum, bladder, and bowel versus X-ray-based treatments.

ProCure generates revenue through professional services billed to Medicare, private insurers, and patients directly; treatment is covered by Medicare and many private insurance providers, with dedicated financial counselors supporting insurance navigation. The go-to-market combines physician referrals and clinical affiliations with major hospital systems (Hackensack Meridian Health, NYU Langone Health, Northwell Health, The Cancer Center at CentraState), a referral relationship with Memorial Sloan Kettering, and physician practice integration with Princeton Radiation Oncology. Demand generation is layered with event-driven patient education (Welcome Wednesdays/Tuesdays information sessions, specialty cancer awareness campaigns) and a content-marketing program of patient testimonials.

ProCure Treatment Centers firmographics

Firmographics
Name
ProCure Treatment Centers
Legal name
ProCure Proton Therapy Center
Website
https://procure.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
251–500 employees
Short description
ProCure Treatment Centers develops and operates proton therapy centers in the United States, operating its flagship Somerset, New Jersey facility delivering Pencil Beam Scanning treatment for prostate, breast, brain, pediatric, and other cancers.
Ownership category
akta.pro rank

ProCure Treatment Centers industry classification

Industry
Product category
Radiation Oncology
NAICS
Offices of Physicians (62111), Diagnostic Imaging Centers (621512)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
akta.pro primary industry
Radiation Oncology (HLAKAFAC)
akta.pro secondary industries
Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB)

Keywords

  • Proton therapy services
  • Radiation oncology
  • Particle beam therapy
  • Pencil beam scanning
  • Cancer treatment centers

Where ProCure Treatment Centers is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ProCure Treatment Centers business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Proton Therapy Treatment Services: ProCure generates revenue by providing proton therapy cancer treatment services to patients. Treatments are billed to insurance providers, Medicare, and patients directly. The center offers treatment for multiple cancer types including prostate, breast, brain, head and neck, lung, gastrointestinal, and pediatric cancers.
  2. Consultation and Information Services: Free information sessions are provided to educate potential patients about proton therapy. Paid consultations are scheduled for patients interested in pursuing treatment.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractInsurance-covered treatment

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

ProCure Treatment Centers product offering

Product offering

Core offering

ProCure Treatment Centers operates the ProCure Proton Therapy Center in Somerset, New Jersey, delivering proton radiation therapy to cancer patients as a direct medical service. The center offers Pencil Beam Scanning treatment across multiple cancer types, supported by a cyclotron, robotic patient positioning, real-time imaging, and SpaceOAR Hydrogel for rectal protection, and accepts patients through physician referrals, hospital partnerships, and direct inquiries.

Product overview

ProCure Proton Therapy Center offers a unified suite of cancer treatment services centered on proton therapy as its core offering. The center provides Pencil Beam Scanning proton therapy as its most advanced treatment option, complemented by SpaceOAR Hydrogel for rectal protection during prostate treatments. Patient-facing services include free Information Sessions, a Patient Portal for health information access, Online Bill Pay, and an Ambassador Program for peer support. The facility also offers facility tours and connects patients to clinical trials. Treatment is available for multiple cancer types including prostate, breast, brain, head and neck, lung, gastrointestinal, and pediatric cancers.

Differentiator

Problem solved

Functional benefit

Products and services

  • Proton Therapy Advanced form of radiation treatment that destroys cancer cells by delivering radiation directly into the tumor and stopping, reducing exposure to surrounding healthy tissue. It is FDA-approved and used to treat prostate, breast, brain, head and neck, lung, gastrointestinal, and pediatric cancers.
  • Free Information Sessions Free educational sessions at the ProCure Somerset facility where prospective patients can learn about proton therapy, meet the care team, and tour the facility.
  • Patient Portal Online portal through ProCure's clinical partner Optimal Care for patients to access their health information and manage their care.
  • Online Bill Pay Online payment service for patients to pay their proton therapy treatment bills through the ProCure website.
  • Ambassador Program Peer support program where former ProCure patients share their experiences with new patients facing similar cancer journeys.
  • Cyclotron Tour Guided tour of ProCure's cyclotron equipment used to generate proton beams for treatment, offered to patients and visitors.

Quantifiable outcome

  • 99% cancer-free rate for early and intermediate prostate cancer at five years post-treatment
  • +5 more outcomes

Companies that use ProCure Treatment Centers

Customer profile

Named customers5 records

Segments7 records

Ideal customer profiles3 records

ProCure Treatment Centers technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

ProCure Treatment Centers partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Hackensack Meridian HealthcoreStrategic or Co-development PartnerClinical affiliation partnership where Hackensack Meridian Health refers patients to ProCure for proton therapy treatment. The partnership enables continued advancement of research and technology for proton therapy. Hackensack Meridian Health is one of the leading hospital systems in New Jersey with top cancer programs.
  • NYU Langone HealthcoreStrategic or Co-development PartnerClinical affiliation with NYU for proton therapy treatment referrals. NYU is a renowned academic medical center with leading cancer programs that collaborates with ProCure to bring proton therapy to patients.
  • Northwell HealthcoreStrategic or Co-development PartnerClinical affiliation with Northwell Health for proton therapy referrals. Northwell Health is one of the largest health systems in New York providing comprehensive cancer care and partners with ProCure to expand access to proton therapy.
  • The Cancer Center at CentraStatecoreStrategic or Co-development PartnerHospital partnership providing comprehensive cancer care beyond proton therapy. The Cancer Center at CentraState offers surgery, chemotherapy, hormone therapy, and immunity therapy, along with palliative care, survivorship programs, and post-treatment wellness resources. The partnership ensures patients receive comprehensive care before, during, and after proton therapy treatment.
  • Princeton Radiation OncologycoreTechnology or IntegrationPhysician practice partnership where radiation oncologists from Princeton Radiation Oncology treat patients at ProCure. Multiple physicians including Dr. Brian Chon, Dr. Henry Tsai, and Dr. Andrew Greenberg work with both ProCure and Princeton Radiation Oncology, enabling seamless patient care and treatment coordination.
  • Memorial Sloan Kettering Cancer CenterminorChannel Partner/ Reseller/ DistributorReferral relationship where Memorial Sloan Kettering refers patients to ProCure for proton therapy when appropriate. Dr. Yu Yao, a radiation oncologist at Memorial Sloan Kettering, referred a nasopharyngeal cancer patient to ProCure for proton therapy treatment.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

ProCure Treatment Centers competitors and assessment

Company assessment

Broad incumbents

  • Elekta: Major radiation therapy equipment manufacturer and solutions provider, including linear accelerators and stereotactic systems. Competes with proton therapy on the cost/benefit axis for conventional radiation oncology.
  • Varian Medical Systems (Siemens Healthineers): Dominant radiation oncology equipment vendor (proton, photon, IMRT, CyberKnife) and increasingly an integrated cancer care operator. Not a direct clinical peer, but shapes the technology and competitive landscape ProCure operates within.

Direct peers

  • Seattle Cancer Care Alliance Proton Therapy: Academic-affiliated proton therapy program treating comparable indications with Pencil Beam Scanning. Overlaps with ProCure in clinical capability and target patient population.
  • Northwestern Medicine Chicago Proton Center: Regional proton therapy center serving the Midwest with cancer indications and technology comparable to ProCure. Geographic non-overlap but same patient mix and referral dynamics.
  • Texas Center for Proton Therapy: Independently operated proton therapy center in the Dallas-Fort Worth area, treating prostate, breast, lung, and pediatric cancers. Comparable standalone model and competitive positioning within a regional market.
  • Provision CARES Proton Therapy Center (Nashville): Independent, privately-financed proton therapy operator with multiple treatment rooms and a similar outpatient, multi-cancer treatment model. Directly comparable as a non-academic, single-market proton center.
  • MD Anderson Proton Therapy Center: High-volume academic proton therapy program treating a similar multi-cancer population (prostate, breast, head/neck, lung, pediatric). Comparable technology stack and physician depth, though embedded in a larger hospital system.
  • Massachusetts General Hospital Burr Proton Therapy Center: One of the original U.S. proton therapy centers, operating at Massachusetts General Hospital with similar Pencil Beam Scanning capability and a tertiary, multi-indication patient mix. Directly comparable clinical model and physician training pathway.
  • Memorial Sloan Kettering Cancer Center Proton Therapy: Operates a multi-room proton facility in the NY metro area, directly competing with ProCure for tri-state patients and referral relationships. Already a referral source for ProCure for select cases.
  • University of Florida Health Proton Therapy Institute: One of the largest standalone proton therapy centers in the U.S., treating a high volume of prostate, breast, lung, head/neck, and pediatric cancers. Closest analog to a multi-state proton therapy network operator.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ProCure Treatment Centers social profiles

Digital presence

ProCure Treatment Centers financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ProCure Treatment Centers leadership team

Management profile

Number of profiles

Profiles11 records

ProCure Treatment Centers funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ProCure Treatment Centers M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ProCure Treatment Centers

What does ProCure Treatment Centers do?

ProCure Treatment Centers operates the ProCure Proton Therapy Center in Somerset, New Jersey, delivering proton radiation therapy to cancer patients as a direct medical service. The center offers Pencil Beam Scanning treatment across multiple cancer types, supported by a cyclotron, robotic patient positioning, real-time imaging, and SpaceOAR Hydrogel for rectal protection, and accepts patients through physician referrals, hospital partnerships, and direct inquiries.

Is ProCure Treatment Centers a public or private company?

ProCure Treatment Centers is a private company. It is classified as venture growth investor backed and is currently operating.

When was ProCure Treatment Centers founded?

ProCure Treatment Centers was founded in 2012. It employs 251 to 500 people.

Where is ProCure Treatment Centers based?

ProCure Treatment Centers is headquartered in New York, United States, in the North America region.

How does ProCure Treatment Centers make money?

Two revenue lines are on record. Proton Therapy Treatment Services are the primary driver. The others are consultation and Information Services.

Who are ProCure Treatment Centers's main competitors?

Broad incumbents on record are Elekta and Varian Medical Systems (Siemens Healthineers). Direct peers are Seattle Cancer Care Alliance Proton Therapy, Northwestern Medicine Chicago Proton Center, Texas Center for Proton Therapy, Provision CARES Proton Therapy Center (Nashville), MD Anderson Proton Therapy Center, Massachusetts General Hospital Burr Proton Therapy Center, Memorial Sloan Kettering Cancer Center Proton Therapy and University of Florida Health Proton Therapy Institute.

Does ProCure Treatment Centers have an API?

No public API is recorded for ProCure Treatment Centers.

What industry is ProCure Treatment Centers in?

ProCure Treatment Centers's product category is Radiation Oncology. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 62111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR Newswire'I HAD EVERY OPTION,' SAYS RADIATION ONCOLOGIST WHO CHOSE PROTON THERAPY AT PROCURE FOR HIS OWN PROSTATE CANCEREdward Soffen, a radiation oncologist, chose proton therapy at ProCure Proton Therapy Center for his own prostate cancer. He evaluated six treatment options and selected protons for their precision, sparing healthy tissue. He trusted the team he has worked with for years.PR NewswireDURING CANCER SURVIVOR MONTH, STATEN ISLAND PATIENT REFLECTS ON WHY PROCURE WAS WORTH THE TRIPTim, a retired NYC prosecutor from Staten Island, underwent 28 proton therapy sessions at ProCure Proton Therapy Center in Somerset, New Jersey, after a prostate cancer diagnosis. The article highlights ProCure's personalized care approach, with Medical Director Dr. Brian Chon providing consultation, ongoing check-ins, and a treatment plan designed to minimize disruption to the patient's daily life. The center, which opened in 2012 as the tri-state region's first proton therapy facility, has treated over 8,000 patients, including more than 750 pediatric cases.YahooDURING CANCER SURVIVOR MONTH, STATEN ISLAND PATIENT REFLECTS ON WHY PROCURE WAS WORTH THE TRIPA retired prosecutor from Staten Island, Tim, reflects on his journey to ProCure Proton Therapy Center in New Jersey for 28 proton therapy sessions during Cancer Survivor Month. His decision was influenced by a strong recommendation from his primary care physician, leading to confidence in his treatment options as outlined by Dr. Brian Chon, the center's Medical Director. ProCure aims to provide exceptional cancer care with personal attention throughout treatment, attracting patients from various regions and even other countries.PR NewswirePROCURE PROTON THERAPY CENTER CELEBRATES JOSEPH AS ITS 8,000TH PATIENTProCure Proton Therapy Center in Somerset, New Jersey celebrated Joseph, a military veteran diagnosed with prostate cancer, as its 8,000th patient. The milestone was reached at the facility that opened in March 2012 and offers proton therapy, a precise radiation treatment targeting tumors while reducing exposure to healthy tissue. The center has now treated over 8,000 patients total, including more than 750 pediatric cases, and expressed commitment to continued innovation in cancer care.YahooPROCURE PROTON THERAPY CENTER CELEBRATES JOSEPH AS ITS 8,000TH PATIENTProCure Proton Therapy Center in Somerset, NJ, celebrated a significant milestone by treating its 8,000th patient, Joseph, a military veteran diagnosed with prostate cancer. This achievement underscores the center's commitment to providing precise cancer care through proton therapy, an innovative treatment method. ProCure aims to continue innovating and improving cancer care accessibility in the tri-state region and beyond.PR NewswireOCTOBER IS BREAST CANCER AWARENESS MONTH: PROCURE URGES WOMEN TO PRIORITIZE EARLY SCREENINGS, UNDERSTAND TREATMENT OPTIONSProCure Proton Therapy Center is urging women to prioritize early breast cancer screenings during October's Breast Cancer Awareness Month. The organization highlights that proton therapy offers a precise, non-surgical radiation option that reduces exposure to healthy organs by 60-70%, potentially lowering side effects and improving quality of life.PR NewswirePROCURE PROTON THERAPY CENTER URGES NEWS ORGANIZATIONS TO RAISE AWARENESS OF THE IMPORTANCE OF EARLY BREAST CANCER DETECTION AND TREATMENT OPTIONSProCure Proton Therapy Center in Somerset, New Jersey, issued a press release urging news media to amplify public awareness of early breast cancer detection and treatment options during Breast Cancer Awareness Month. The center highlighted that when detected early, breast cancer has a 99% survival rate and noted that proton therapy offers precise radiation treatment that reduces exposure to the heart and lungs. ProCure also positioned itself as accessible to patients from the New York and Philadelphia metropolitan areas and emphasized it accepts various insurance plans.PR NewswireSEPTEMBER IS PROSTATE CANCER AWARENESS MONTH: PROCURE PROTON THERAPY CENTER ENCOURAGES MEN TO LEARN ABOUT THEIR OPTIONSProCure Proton Therapy Center in Somerset, NJ is using Prostate Cancer Awareness Month in September to educate men about proton therapy as an FDA-approved treatment option for prostate cancer, highlighting that the therapy can reduce unnecessary radiation to the bladder and bowels by 60–70% compared to conventional radiation. The center, which opened in 2012 as the tri-state region's first proton therapy facility, has treated more than 7,400 patients and emphasizes that proton therapy allows precise targeting of cancer while sparing nearby healthy tissue. The article encourages men to consult their doctors about treatment options and notes that the therapy is covered by many insurance plans.PR NewswirePROCURE PROTON THERAPY CENTER URGES NEWS ORGANIZATIONS TO RAISE AWARENESS OF PROTON THERAPY FOR PROSTATE CANCERProCure Proton Therapy Center in Somerset, New Jersey is calling on news media to help educate the public about proton therapy as a treatment option for prostate cancer, citing that the condition affects one in eight men. The center states that proton therapy, which has been FDA-approved since 1988, can reduce unnecessary radiation to the bladder and bowels by 60-70% compared to conventional radiation while sparing healthy tissue. ProCure, which opened in March 2012 as the tri-state region's first proton therapy facility, says it has treated over 7,400 patients including more than 750 pediatric cases.PR NewswirePRIORITIZE PROSTATE SCREENING--IT'S THE BEST DEFENSE AGAINST PROSTATE CANCER, SAYS PROCUREProCure Proton Therapy Center in Somerset, New Jersey issued a press release reminding men about the importance of prostate-specific antigen (PSA) screenings for early prostate cancer detection, citing recent JAMA studies linking reduced screening rates to increased late-stage diagnoses. The facility, which opened in 2012 and has treated over 7,400 patients, recommends that men aged 40 and older discuss screening with their physicians. The article also promotes proton therapy as a non-surgical treatment option with potentially fewer side effects.